Coronary stents: historical development, current status and future directions.
نویسندگان
چکیده
INTRODUCTION Coronary angioplasty with stenting has revolutionized the treatment of coronary artery disease. This article describes the history of coronary angioplasty and stenting, reviews the contemporary stents and recommendations and highlights the on-going work and potential future directions. SOURCES OF DATA This review examined the data on coronary stents available in PubMed. AREAS OF AGREEMENT Coronary artery stenting is the treatment of choice for patients requiring coronary angioplasty. Stents, and particularly drug-eluting stents, reduce the risk of restenosis, but may be associated with the hazard of late stent thrombosis. Dual anti-platelet treatment is recommended for patients receiving coronary stents. AREAS OF CONTROVERSY The selection of stents for various lesions and patients and the duration of anti-platelet therapy remain debated areas. AREAS TIMELY FOR DEVELOPING RESEARCH There are on-going preclinical and clinical studies to develop better stent platforms, more biocompatible polymers, novel anti-proliferative and anti-platelet drugs, pro-healing stents and bioresorbable scaffolds.
منابع مشابه
Stents for intracoronary placement: current status and future directions.
The technique of intracoronary stenting has achieved remarkable progress over the last few years. Improved stent deployment techniques and optimization of postprocedural management have dramatically improved the safety of intracoronary stent placement. At present, the incidence of early vessel closure after stenting is even lower than that after standard angioplasty and, as most operators no lo...
متن کاملProgress in treatment by percutaneous coronary intervention: the stent of the future.
First generation drug-eluting stents have considerably reduced in-stent restenosis and broadened the applications of percutaneous coronary interventions for the treatment of coronary artery disease. The polymer is an integral part of drug-eluting stents in that, it controls the release of an antiproliferative drug. The main safety concern of first generation drug-eluting stents with permanent p...
متن کاملClassification and current treatment options of in-stent restenosis. Present status and future perspectives.
Coronary stent implantation is currently performed in > 80% of percutaneous coronary interventions. Its main late complication is the development of in-stent restenosis (ISR), occurring in 10-80% of lesions treated in daily practice. The classification by Mehran et al. is most commonly used. Current therapeutic options to treat ISR include repeat balloon angioplasty, repeat stenting, cutting ba...
متن کاملCoronary Stent Evolution – from Pathology to Clinic
Coronary artery disease (CAD) is the leading cause of morbidity and mortality worldwide. The pathogenesis of CAD relates to the presence of atherosclerotic plaques in coronary arteries, which are today most frequently treated by percutaneous coronary intervention. Initially, plain old balloon angioplasty demonstrated feasibility of dilating atherosclerotic coronary lesions; however, the high ra...
متن کاملCoronary stents: current status.
Coronary artery stents revolutionized the practice of interventional cardiology after they were first introduced in the mid-1980s. Since then, there have been significant developments in their design, the most notable of which has been the introduction of drug-eluting stents. This paper reviews the benefits, risks, and current status of Food and Drug Administration-approved drug-eluting stents.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- British medical bulletin
دوره 106 شماره
صفحات -
تاریخ انتشار 2013